Studies [18] regarding the direct testing of BRCA mutations and variants showed that these mutations marked increase ovarian cancer with SIR values of 139.12 (BRCA1) and 74.93 (BRCA2), whereas the effects in other cancers mostly have SIR values of around 1–2. This evidence concerns the gene BRCA1 and ovarian cancer.